CN Patent

CN117137912A — 选择性s1p1受体激动剂的给药方案

Assigned to Zhuweis Pharmaceutical Laboratory Co ltd · Expires 2023-12-01 · 2y expired

What this patent protects

本发明涉及一种选择性S1P 1 受体激动剂的给药方案，具体地涉及(R)‑5‑[3‑氯‑4‑(2,3‑二羟基‑丙氧基)‑苯[Z]亚甲基]‑2‑([Z]‑丙基亚氨基)‑3‑邻‑甲苯基‑噻唑烷‑4‑酮的给药方案。

USPTO Abstract

本发明涉及一种选择性S1P 1 受体激动剂的给药方案，具体地涉及(R)‑5‑[3‑氯‑4‑(2,3‑二羟基‑丙氧基)‑苯[Z]亚甲基]‑2‑([Z]‑丙基亚氨基)‑3‑邻‑甲苯基‑噻唑烷‑4‑酮的给药方案。

Drugs covered by this patent

Patent Metadata

Patent number
CN117137912A
Jurisdiction
CN
Classification
—
Expires
2023-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Zhuweis Pharmaceutical Laboratory Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.